Titre:
  • Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: A retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy
Auteur:Bozovic-Spasojevic, Ivana; Ameye, Lieveke; Paesmans, Marianne; Larsimont, Denis; Di Leo, Angelo; Dolci, Stella; Azambuja, Evandro; Piccart-Gebhart, Martine; Loi, Sherene
Informations sur la publication:Breast, 23, 4, page (473-481)
Statut de publication:Publié, 2014
Sujet CREF:Chirurgie
Mots-clés:BCL2
Biomarkers
Breast cancer
Expression
Prognosis
TP53
MeSH keywords:Adult
Aged
Antibiotics, Antineoplastic -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Axilla
Breast Neoplasms -- drug therapy -- metabolism -- pathology
Carcinoma, Ductal, Breast -- drug therapy -- metabolism -- pathology
Carcinoma, Lobular -- drug therapy -- metabolism -- pathology
Chemotherapy, Adjuvant
Cisplatin -- therapeutic use
Disease-Free Survival
Epirubicin -- therapeutic use
Female
Fluorouracil -- therapeutic use
Humans
Lymph Nodes -- metabolism -- pathology
Methotrexate -- therapeutic use
Middle Aged
Prognosis
Proto-Oncogene Proteins c-bcl-2 -- metabolism
Retrospective Studies
Treatment Outcome
Tumor Markers, Biological -- metabolism
Tumor Suppressor Protein p53 -- metabolism
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2014.03.012
info:pii/S0960977614000563
info:scp/84902548579
info:pmid/24768477